trending Market Intelligence /marketintelligence/en/news-insights/trending/8k9EclHboE3R6OkYpp7e7A2 content esgSubNav
In This List

Anavex Life Sciences: Appeal in Cortina lawsuit dismissed

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Anavex Life Sciences: Appeal in Cortina lawsuit dismissed

Anavex Life Sciences Corp. said the appeal in Cortina v. Anavex Life Sciences Corp. was dismissed.

No fees or costs were incurred by the company, and the matter had come to a full and final conclusion.

The lawsuit was filed by Kevin Cortina in the U.S. District Court for the Southern District of New York, claiming that the biopharmaceutical company had made materially false and misleading statements regarding its business, operational and compliance policies.